| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | PLSE Pulse Biosciences, Inc. | Danahy Kevin Patrick85 | Chief Commercial Officer | Sell | 5,000 | $23.64 | $118,200.00 | -10.4% | -2.0% | - | |
| Feb 18, 2026 | ALGN Align Technology, Inc. | Morici John61 | EVP, Chief Financial Officer | Sell | 7,969 | $189.31 | $1,508,645.66 | -49.2% | -18.7% | - | |
| Feb 18, 2026 | SINT Sintx Technologies, Inc. | Anderson Mark Lewis | Director | Buy | 3,000 | $3.02 | $9,060.00 | +20.0% | -26.7% | - | |
| Feb 18, 2026 | ATR Aptargroup, Inc. | Touya Gael59 | Segment President | Sell | 3,500 | $141.35 | $494,738.65 | -11.1% | -19.8% | - | |
| Feb 17, 2026 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 3,361 | $3.35 | $11,259.35 | -3.2% | +11.7% | - | |
| Feb 17, 2026 | OM Outset Medical, Inc. | Nash Marc83 | EVP Operations R&D &Service | Sell | 1,817 | $3.35 | $6,086.95 | -4.3% | +11.7% | - | |
| Feb 17, 2026 | KMTS Kestra Medical Technologies, Ltd. | Webster Brian Daniel60 | See Remarks | Sell | 15,000 | $25.60 | $384,019.60 | -1.3% | -24.0% | - | |
| Feb 17, 2026 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 2,842 | $3.35 | $9,520.70 | -7.9% | +11.7% | - | |
| Feb 13, 2026 | QDEL Quidelortho Corp | Blaser Brian J. | President And CEO | Buy | 10,540 | $23.59 | $248,660.73 | +35.7% | -51.7% | - | |
| Feb 12, 2026 | IRIX Iridex Corp | Dizon Romeo R57 | Chief Financial Officer | Buy | 1,500 | $1.43 | $2,145.00 | +1.3% | -25.4% | - | |
| Feb 12, 2026 | DXCM Dexcom Inc | Heller Bridgette P62 | Director | Sell | 1,012 | $68.01 | $68,826.12 | -3.7% | -10.0% | - | |
| Feb 10, 2026 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, CLO And Cs | Sell | 3,485 | $1.55 | $5,401.75 | -0.5% | +13.4% | - | |
| Feb 10, 2026 | ATR Aptargroup, Inc. | Prieur Marc66 | Segment President | Sell | 2,000 | $137.81 | $275,620.00 | -12.7% | -13.7% | - | |
| Feb 10, 2026 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 40,976 | $1.55 | $63,512.80 | -2.5% | +13.4% | - | |
| Feb 5, 2026 | SYK Stryker Corp | Stryker Ronda E57 | Director | Sell | 500,000 | $363.44 | $181,719,268.57 | -1.1% | -19.3% | - | |
| Feb 4, 2026 | RPID Rapid Micro Biosystems, Inc. | Longitude Capital Partners Ii, LLC | 10% Owner | Sell | 49,000 | $3.88 | $190,090.60 | -100% | -36.2% | - | |
| Feb 4, 2026 | RSMDF Resmed Inc | Farrell Peter C54 | Director | Sell | 2,000 | $251.31 | $502,620.00 | -3.0% | - | - | |
| Feb 4, 2026 | RSMDF Resmed Inc | Rider Michael J47 | Global General Counsel | Sell | 50 | $260.00 | $13,000.00 | -0.5% | - | - | |
| Feb 4, 2026 | ABT Abbott Laboratories | Starks Daniel J53 | Director | Buy | 10,000 | $108.73 | $1,087,331.40 | - | -19.4% | - | |
| Feb 3, 2026 | CBLL Ceribell, Inc. | Foehr David | Senior VP, Finance And Pao | Sell | 5,556 | $20.00 | $111,120.00 | -12.8% | +0.1% | - | |
| Feb 3, 2026 | IRIX Iridex Corp | Dizon Romeo R57 | Chief Financial Officer | Buy | 2,500 | $1.38 | $3,450.00 | +2.2% | -27.5% | - | |
| Feb 2, 2026 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 337 | $16.42 | $5,532.09 | -3.3% | -19.3% | - | |
| Jan 30, 2026 | ELUT Elutia Inc. | Neels Guido J69 | Director | Buy | 20,000 | $1.04 | $20,800.00 | +20.3% | -2.9% | - | |
| Jan 29, 2026 | IRIX Iridex Corp | Dizon Romeo R57 | Chief Financial Officer | Buy | 1,101 | $1.44 | $1,587.64 | +1.0% | -30.9% | - | |
| Jan 29, 2026 | ELUT Elutia Inc. | Neels Guido J69 | Director | Buy | 30,000 | $1.06 | $31,800.00 | +19.7% | -4.8% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.